Immunosuppression and COVID-19 Boosters
Immunosuppression and COVID-19 Boosters
Recruiting · NCT05415267 · Registry updated 2026-02-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Immunosuppression and COVID-19 Boosters | COVID-19, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Recruiting | Phase 3 | 2026-02-24 | NCT05415267 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Kirby Institute | 19 |
| Medical Research Future Fund | 16 |
| Seqirus Pty Ltd, Australia | 1 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Blacktown Hospital | Blacktown | Australia | 18 |
| Concord General Repatriation Hospital | Concord | Australia | 1 |
| Royal Prince Alfred Hospital | Camperdown | Australia | 83 |
| St Vincent's Hospital, Sydney | Darlinghurst | Australia | 2 |
| Westmead Hospital | Westmead | Australia | 128 |